283 results
Page 5 of 15
424B2
mw8j6 ehuac
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-10.1
jeom 7mdibnqp8co
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.2
0q4f03gjj 7pedn
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-10.1
iwxfcttd74
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-99.1
q8q p6lpht76r9bb
10 Aug 20
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
5:00pm
8-K
EX-10.1
umuhujoive3v
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-4.1
0y5nj5udezj4o6ghjh3
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
qg0kfq09 5n3dq
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-99.1
dek5kcau l2tx8wpktys
11 May 20
Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
4:58pm
8-K
EX-4.1
mbtee 45v1auxim7wn3p
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-4.2
gtklqtlmov7rnzfjt zb
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-10.2
rcyj86nuwadt
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
8-K
EX-99.2
lccgd
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm